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Abstract
Influenza A viruses were isolated in Vero, MDCK cells and chicken embryos. In contrast to MDCK-derived variants all H3N2 isolates
obtained in Vero cells neither agglutinated chicken erythrocytes nor grew in chicken eggs. These host range differences of H3N2 Vero and
MDCK isolates were noticed even in the absence of amino acid substitutions in the HA1 molecule. Evaluation of HA glycosylation pattern
by treatment with endoglycosidases H and F revealed that Vero-variants contained more oligosaccharides of the high mannose type than
did the corresponding MDCK-isolates. Removal of some mannose residues from the non-reducing termini of the carbohydrates by
exomannosidase treatment resulted in the ability of Vero-isolates to agglutinate chicken erythrocytes. Glycosylation pattern and properties
of H3N2 viruses grown in Vero cells were close to those of viruses grown in human kidney epithelial cells, whereas the H1N1 variants
isolated from Vero, MDCK cells or eggs did not differ in agglutination properties, carbohydrate composition or ability to infect eggs.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Influenza virus infection is initiated by virus binding to
sialic acid on cell surface glycoproteins or glycolipids. After
absorption the virus enters the cell by endocytosis followed
by hemagglutinin (HA) mediated fusion of viral and endo-
somal membranes. Depending on the origin of the cells used
for isolation of influenza A and B viruses from clinical
specimens, various receptor binding mutants have been ob-
tained. Isolation and propagation of human influenza vi-
ruses in chicken eggs (CE) or in the BHK-21 cell line results
in the selection of variants distinct from original viruses
containing amino acid substitutions in the vicinity of the HA
receptor binding site (RBS) (Azzi et al., 1993; Govorkova et
al., 1999; Katz et al., 1987; Robertson, 1999; Robertson et
al., 1985; Schild et al., 1983). In contrast, the HA molecules
of viruses isolated in some mammalian cell lines such as
MDCK, LLC-MK-2, MRC-5 or Vero usually were found to
be antigenically and structurally identical to the strains
present in the swabs of influenza patients (Govorkova et al.,
1995; Katz et al., 1990; Katz and Webster, 1992; Rajakumar
et al., 1990; Robertson et al., 1990, 1991; Schepetiuk and
Kok, 1993).
A possible molecular mechanism of variant selection is
most likely related to their different affinity for various cell
receptors (Gambaryan et al., 1997, 1999). Influenza strains
isolated in mammalian cell lines preferentially bind to sialic
acid linked to the penultimate galactose at position 2,6
(Sia(2,6)Gal), dominating on the surface of human respi-
ratory epithelium cells (Baum and Paulson, 1990; Couceiro
et al., 1993). Viruses produced in CE prefer the
Sia(2,3)Gal containing receptors, more typical for avian
species (Ito et al., 1997; Suzuki, 1994). The different recep-
tor binding properties of viral isolates could be determined
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by amino acid changes adjacent to the HA RBS (Almond,
1977; Connor et al., 1994; Gambaryan et al., 1999; Gam-
baryan et al., 1997; Govorkova et al., 1999; Matrosovich et
al., 1998; Matrosovich et al., 1997; Rogers and D’Souza,
1989; Vines et al., 1998) or by mutations affecting the
glycosylation sites on the tip of the HA molecule (Gam-
baryan et al., 1998).
Recently we found that H3N2, but not H1N1, viruses
isolated from the Vero cell line cultivated in serum free
medium or in the MDCK cell line cultivated in medium
with only 2% of fetal calf serum (FCS) had different ag-
glutination properties with human red blood cells (HRBC)
or chicken red blood cells (CRBC) (Grassauer et al., 1998).
Moreover, it has been demonstrated by the reverse genetics
method that only the HA molecule was responsible for this
phenomenon (Grassauer et al., 1998). In the present study
we demonstrate that the different agglutination pattern and
host range of H3N2 isolates could be determined by the host
dependent glycosylation even in the absence of amino acid
substitutions in the HA1 molecule. We have found that the
composition of the carbohydrates attached by Vero and
MDCK cells to the HAs with identical primary structures
was not identical. Viruses isolated in Vero cells (V) had
more oligosaccharides of high mannose type than corre-
sponding MDCK-isolates (M). In addition we demonstrated
that after propagation of H3N2 V-isolates in the human
kidney cell line HK42/1 viruses preserved their agglutina-
tion properties and glycan type.
Results
Hemagglutination pattern of influenza A viruses isolated
in different systems
Influenza viruses of the A(H3N2) subtype were iso-
lated in Vero and MDCK cell lines but not after two
passages in the amniotic cavity of CE. Viruses were
subtyped using sheep diagnostic antisera (NIBSC) by a
standard HI test. No H3N2 V-isolates were able to ag-
glutinate CRBC and infect CE (Table 1). In contrast,
viruses isolated in MDCK cells were able to agglutinate
CRBC as well as HRBC and were infectious for CE. The
agglutination phenotype of H3N2 V-isolates was stable
while passaging in Vero cells or the human kidney cell
line HK42/1. However, a single passage in MDCK cells
was sufficient to convert it to the phenotype of M-vari-
ants. Conversely, after one passage of M-variant in Vero
cells we have observed 8 time reduction of virus hemag-
glutination activity toward CRBC. An egg grown (E)
H3N2 variant was obtained only after two subsequent
passages of the A/HK/1180/99 V-isolate using a high
(105 p.f.u./egg) multiplicity of infection (m.o.i.). This
variant designated as A/HK/1180/99VE was able to ag-
glutinate CRBC. A(H1N1) influenza viruses isolated
from both continuous cell lines and CE neither displayed
differences in agglutination properties nor in the ability
to infect CE.
Table 1
Agglutination properties and sequence differences of influenza viruses isolated in different hosts
Isolates Passage
historya
Agglutination of Growth in
CE
Substitutions in HA1
compared to swab
virusCRBC HRBC
H3N2
A/HK/1143/99 2V 2 32 
2M 32 32  Asn133 3 Asp
Gly218 3 Glu
A/HK/1179/99 2V 2 32 
2M 128 64  Arg220 3 Ser
A/HK/1182/99 2V 2 64 
2M 32 32 
A/HK/1180/99 2V 2 16 
2M 16 32 
2V1H 2 16  n.t.b
2V2E 32 64  Leu194 3 Ileu
Arg220 3 Ser
2V2E1V 32 64  n.t.
2V1M 16 32 
2V3M 64 64  Arg220 3 Gly
H1N1
A/HK/1035/98 2V 32 32 
2M 64 64 
2E 64 64  Asp225 3 Gly
A/HK/1134/98 2V 16 16 
2M 32 32 
2E 64 64  Gln226 3 Arg
a Passage history with the number of passages in Vero (V), MDCK (M) or HK42/1 (H) cell lines or chicken eggs (E).
b n.t. not tested.
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Amino acid changes in HA, NA and M genes of viruses
isolated in different hosts
To define the amino acid residues involved in the differ-
ent agglutination properties of V- and M-isolates and to
elucidate which host system supports the isolation of orig-
inal human viruses, we compared the HA nucleotide se-
quences of V-, M-, E- and swab (S) viruses. First we found
that the HA1 sequences of all four A(H3N2) V-isolated
viruses were identical to that of the original viruses present
in the clinical specimen (Table 1). The results for the M-
isolated viruses were less consistent. The virus A/HK/1143/
99M had two substitutions in HA1 comparing to the S-virus
at positions 133 (Asn 3 Asp) and 218 (Gly 3 Glu). The
first substitution resulted in the loss of a potential glycosyl-
ation site at the position 133–135 located at the right edge of
the virus RBS (Nobusawa et al., 1991) while the second one
218 (Gly 3 Glu) was related to a charge shift. The second
virus A/HK/1179/99M differed from the S-virus at the po-
sition 220 having charged Arg substituted by a neutral Ser.
Surprisingly, two of the M-isolates, A/HK/1180/99M and
A/HK/1182/99M, had the same HA1 sequence as their S-
and V-counterparts despite different agglutination proper-
ties and their capacity to grow in CE. These results sug-
gested that differences in posttranslational modifications
were responsible for the contrasting agglutination proper-
ties. When the virus A/HK/1180/99V, noninfectious for
eggs, was passaged twice in CE with high m.o.i. a variant
capable to agglutinate CRBC was selected. This virus ac-
quired two substitutions in the HA1 subunit at positions 194
(Leu3 Ile) and 220 (Arg3 Ser). The position 194, being
a part of the virus RBS, was shown to be involved in the
ability of modern H3N2 viruses to agglutinate CRBC (Me-
deiros et al., 2001). The second change 220 (Arg 3 Ser)
was described above as discriminating V- and M-variants of
A/HK/1179/99.
Viruses A/HK/1180/99 V and M carrying the identical
HA1 primary structure were additionally analyzed for the
sequences of the neuraminidase (NA) and matrix (M) genes
since it was shown that these genes could have an impact on
the agglutination phenotype of influenza viruses (Tong et
al., 1998; Wagner et al., 2000). The sequencing of NA gene
of V- and M-variants revealed one amino acid difference at
position 136 (Gln 3 Arg), respectively. The M gene prod-
ucts of these isolates were identical. Therefore it was con-
cluded that agglutination differences of V- and M-isolates
could be related to the point mutation in NA or to host
dependent glycosylation pattern of the viral glycoproteins.
Analysis of the two A(H1N1) viruses A/HK/1035/98 and
A/HK/1134/98 revealed the identity of the HA1 sequences
of both V- and M-isolates to that present in the swabs (Table
1). Isolation of H1N1 viruses in CE led to the appearance of
the substitutions 225 (Asp 3 Gly) or 226 (Gln 3 Arg) in
the HA1 subunit which are known as specific for avian
influenza viruses (Matrosovich et al., 2000; Matrosovich et
al., 1997; Rogers and D’Souza, 1989).
Oligosaccharide composition of the HA of viruses isolated
in different hosts
To determine whether the distinct agglutination pheno-
type of variants isolated in different cell substrates could be
attributed to host specific glycosylation pattern, viruses with
identical HA primary structure were analyzed by PAGE and
Western blotting.
Comparison of the migration rates of HA1 and HA2
bands of V-and M-variants of A/HK/1180/99 (H3N2) virus
(Fig. 1A, Lanes 1, 2) indicated that both subunits of the
M-isolate migrated slower than the corresponding bands of
the V-isolate. This difference presumably reflects the higher
molecular weight of the oligosaccharides attached to the HA
by MDCK cells when compared to those attached by Vero
cells.
Treatment of V- and M-variants with two enzymes, Endo
H and Endo F, was used to characterize the amount and the
types of oligosaccarides present on the HA. Endo H cleaves
only certain high mannose and hybrid oligosaccharides car-
rying a specific mannose residues, while Endo F cleaves
high mannose, hybrid and complex N-linked oligosaccha-
rides (Fukuda and Kobata, 1993). Purified viruses were
denaturated prior to digestion to convert trimeric subunits
into monomers for facilitating the cleavage. It should be
mentioned that HA1 subunits of both variants consisted of
two bands after digestion which persisted at a higher en-
zyme concentration and longer incubation period (Fig. 1A,
Lanes 4, 5). These bands reflect the glycan microheteroge-
neity which depends on the cell growth stage (Muramatsu et
al., 1976). However, the mobility rate of both bands of the
HA1 subunit of the M-variant after Endo H digestion was
significantly slower than the one of the V-variant. After
treatment with Endo F used as a positive control, both
variants (Fig. 1, Lanes 7 and 8) demonstrated equal mobility
of HA1 and HA2 bands indicating that all oligosaccharides
were cleaved from the HA molecule. An important obser-
vation was that both HA subunits of the variant isolated in
Vero cells and then grown in human HK42/1 cells (desig-
nated as A/HK/1180/99VH) migrated absolutely identically
to those of the original A/HK/1180/99V virus before and
after digestion with both endoglycosidases (Fig. 1A, Lanes
3, 6, 9).
The fact that both HA1 bands of the M-isolate migrated
significantly slower after treatment with Endo H than the
ones of the V-isolate might have two explanations: less high
mannose side chains were attached to the HA1 of the M-
variant, or the remaining complex oligosaccharides of the
M-variant had a significantly higher molecular weight. Ad-
ditional information was obtained after Endo H digestion of
HAs under non denaturing conditions. Treatment of both
native V- and M-variants with Endo H resulted in a stepwise
removal of N-linked oligosaccharides from the HA1 subunit
of both variants (Fig. 1B). However, the number of N-
glycans cleaved from V-variant was higher than from M-
variant indicating that more high mannose or hybrid chains
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were exposed on the surface of the HA trimer of the V-
variant. This result suggested that high mannose or hybrid
chains present at the HA surface of the V-variant might be
involved into distinct host range of the V- and M-isolates.
Similar experiments with H1N1 V-, M- and E-variants of
virus A/HK/1035/98 confirmed a higher molecular weight
of the oligosaccharides attached to the HA grown in MDCK
cells compared to the chains synthesized by Vero cells or
CE (Fig. 1C, Lanes 1, 2, 3). At the same time treatment with
Endo H and Endo F of denatured HAs of these variants did
not reveal any differences in their digestion profiles. This
indicated that probably the same number of complex plus
high mannose type chains were attached to the H1N1 HAs
of V-, M- and E-variants while complex oligosaccharides of
the M-variant are larger than those of the V- and E-variants.
Besides, all H1N1 variants probably contained less high
mannose oligosaccharides than the H3N2 viruses as could
be judged from the mobility of the HA1 subunit after Endo
H treatment (Fig. 1C, Lanes 4–6).
Role of high mannose oligosaccharides of HA in virus
binding to CRBC
To investigate the involvement of different carbohy-
drates in the agglutination phenotype of H3N2 viruses,
several V-isolated variants were treated with exoglycosi-
dases which remove terminal sugars from the non-reducing
termini of high mannose or complex carbohydrate chains.
Two combinations of enzymes were used: the first mixture
(mix 1) consisted of two -mannosidases which cleave
mannose 1–2, 3 and 6 linkages. The second mixture (mix
2) included -galactosidase and -N-acetylglucosaminidase
specific for terminal 1–4 galactose residues and -linked
N-acetylhexosamine residues of oligosaccharides. Before
addition of mix 2, viruses were treated with Vibrio cholerae
NA to remove possible terminating sialic acids from the
complex oligosaccharides. As shown in Fig. 2 treatment
Fig. 1. SDS–PAGE and Western blotting analysis of the HA polypeptides
of A/HK/1180/99 (H3N2) and A/HK/1035/98 (H1N1) viruses isolated in
different hosts following treatment with Endo H and Endo F. A. The HA
subunits of V-, M- and VH-variants of A/HK/1180/99 virus treated with
Endo H (h) and Endo F (f) enzymes at denaturing conditions. Lanes: M:
molecular size marker; 1, 2, 3: untreated control (c) variants Mc, Vc, VHc,
respectively; 4, 5, 6: variants treated with Endo H (Mh, Vh, VHh); 7, 8, 9:
variants treated with Endo F (Mf, Vf, VHf). B. The HA subunits of V- and
M-variants of A/HK/1180/99 virus treated with Endo H at non denaturing
conditions. Lanes: 1, 2: variants Mh, Vh, respectively. C. The HA subunits
of M-, V- and E-variants of A/HK/1035/98 virus treated with Endo H and
Endo F enzymes at denaturing conditions. Lanes: M: molecular size mark-
er; 1, 2, 3: untreated control samples (Mc, Vc, Ec); 4, 5, 6: variants treated
with Endo H (Mh, Vh, Eh); 7, 8, 9: variants treated with Endo F (Mf, Vf,
Ef, respectively).
Fig. 2. Agglutination titers and infectivity for CE of A/HK/1182/99V virus
after exoglycosidase treatment. Purified influenza virus A/HK/1182/99V
was digested with -exomannosidases (mix 1) or with -galactosidase and
-N-acetylglucosaminidase (mix 2) as described in Materials and methods.
Hemagglutination assay was performed with CRBC (white bars) and
HRBC (black bars). 10-days old CE were infected with 106 p.f.u./egg of
untreated virus (control) or virus treated with enzyme mixtures. Virus yield
was assessed after 48 h by titration of hemagglutination in allantoic fluid of
each egg. Results are presented as the ratio of the CE with positive
hemagglutination to total amount of infected eggs.
Fig. 3. Effect of exoglycosidase treatment on the HA oligosaccarides of
A/HK/1182/99V (H3N2) virus. Purified native influenza virus A/HK/1182/
99V was digested with -exomannosidases (mix 1) or with -galactosidase
and -N-acetylglucosaminidase (mix 2) as described in Materials and
methods. Samples were subjected to SDS PAGE and Western blotting.
Lanes: M: molecular size marker; 1: virus treated with mix 1; 2: virus
treated with mix 2.
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with -mannosidases of virus A/HK/1182/99V induced an
increased agglutination titer with CRBC from 10 to 1:40
and with HRBC from 1:40 to 1:160. Moreover, enhanced
agglutination activity of this virus was accompanied by
capacity to infect CE. A similar effect was shown for A/HK/
1143/99V, A/HK/1179/99V and A/HK/1180/99V viruses
(data not shown). Liberation of some residues from the
carbohydrate chains by mix 1 was confirmed by the shift in
the mobility of the HA1 band after digestion comparing to
the position of the band of the untreated virus (Fig. 3, Lanes
1, 2). These results indicated that some of the high mannose
chains probably were located in the proximity of the RBS
and interfered with hemagglutination activity and infectious
potential of V-isolated viruses for the cells of chicken ori-
gin. Treatment of this virus with neuraminidase alone (data
not shown) or in combination with -galactosidase and
-N-acetylhexosaminidase did not enhance the agglutina-
tion activity with both types of erythrocytes or infectivity
for CE, although the slight mobility shift of the HA1 subunit
after digestion indicated that at least some glycans were
trimmed by this combination of enzymes (this could be
compatible with the presence of some hybrid N-glycans)
(Fig. 3, Lane 3). Therefore it is likely that the complex
oligosaccharides of V-isolates are not involved in the re-
ceptor binding activity.
Discussion
During several recent influenza seasons we constantly
observed the same phenomenon for H3N2 influenza A vi-
ruses: variants isolated from clinical samples in Vero and
MDCK cell lines were different in their agglutination prop-
erties. V-variants in contrast to M-isolated viruses were
neither capable of agglutinating CRBC nor of infecting CE.
At the same time experiments with H1N1 isolates gave
identical results for both properties regardless of which of
the two cell lines was used.
Sequence data revealed that all V-isolated viruses for
both H3N2 and H1N1 subtypes were always indistinguish-
able from the original clinical sample in their HA1 se-
quence. The results for the M-grown viruses were less
consistent. While the H1N1 V- and M-isolates had identical
HA1 sequences compared to the swab virus, H3N2 M-
viruses sometimes contained one or two amino acid substi-
tutions located in the vicinity of the HA RBS. However, in
several cases the H3N2 V- and M-isolates were identical in
the HA sequence but still remaining their distinct host
range.
Using V- and M-isolates of H3N2 and H1N1 viruses
having identical HA sequences, we have demonstrated that
carbohydrate moieties of M-grown viruses had higher mo-
lecular weight than those present in V-variants. Moreover,
the composition of carbohydrates attached to the H3N2 HA
molecules by Vero and MDCK cells was not identical.
Using Endo H and Endo F enzyme treatment we have
demonstrated that from the same total amount of potential
glycosylation sites, around 5 high mannose or hybrid chains
were exposed on the surface of the HA globular part of
H3N2 V-grown isolate, while definitely less were attached
to the HA1 of the M-grown virus. Next, we have shown that
treatment of viruses by exomannosidases leading to the
partial removal of mannose residues from the non-reducing
termini of high mannose or hybrid glycans resulted in the
ability of V-grown viruses to agglutinate CRBC and to
infect CE. Presumably, the predominance of high mannose
chains in the close proximity of the virus RBS determines
the narrowed host specificity of the H3N2 V-isolates.
In contrast to H3N2 viruses the HA1 subunits of V-, M-,
and E- H1N1 variants had probably the same total number
of high mannose plus complex oligosaccharides but with a
predominance of complex chains. In general, the HA of
recent A(H1N1) viruses is less glycosylated than that of
H3N2 viruses. The HA molecule of H1N1 viruses contains
only 7 potential glycosylation sites comparing to 9–10 sites
found on the HA of H3N2 viruses investigated in our study.
Thus, the degree of the HA glycosylation of influenza vi-
ruses might explain the different behavior of modern highly
glycosylated H3N2 and less glycosylated H1N1 viruses
after isolation in Vero and MDCK cell lines.
An important observation in our experiments was that
one passage of H3N2 V-isolated virus in MDCK cells was
sufficient to induce the ability to agglutinate CRBC and to
replicate in CE. This dramatic change of the virus host range
is induced therefore by the change in the glycosylation
pattern provided by MDCK cells rather than by amino acid
substitutions. Serial passages of V-isolates in MDCK cells
induced mutations in the HA similar to those found after
direct isolation of the viruses in MDCK cells or propagation
in CE. It is not clear why MDCK cells provided the broader
host range for H3N2 viruses allowing them to grow in avian
cells. Nevertheless our results, in accordance with others,
showed that viruses grown in MDCK cells have larger
glycans when compared to those of the viruses grown in CE
(Inkster et al., 1993) or Vero cells. Bulky complex type
glycans of H3N2 M-variant located near the RBS might
interfere with the HA binding activity (Gambaryan et al.,
1998; Kemble et al., 1993), especially if they are sialylated
(Ohuchi et al., 1997). Theoretically, this could explain why
some H3N2 M-isolates have not been grown in MDCK cells
without acquiring amino acid substitutions in HA leading to
the loss of one of the potential HA glycosylation sites or to
a charge shift. It should be mentioned that the properties of
MDCK cell lines used in other laboratories could influence
the phenotype of propagated viruses due to different culti-
vation conditions (Medeiros et al., 2001; Morishita et al.,
1996; Nobusawa et al., 2000). If the Endo H sensitive
glycans are oligomannosidic, then glycans dominating on
the surface of V-isolates do not carry the sialic acids and
tend to be of smaller size. However, the possibility remains
that the V-isolate Endo H sensitive glycans are of the hybrid
type (particularly since we observed a small shift after
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treatment with mix 2). Mammalian glycoproteins carrying
only oligomannosidic glycans are probably not so common,
but glycopeptides isolated from human diploid fibroblasts
tend to carry predominantly such structures (Muramatsu et
al., 1976). Moreover, the glycosylation machinery provided
by Vero cells appears to be similar to that of human kidney
cells. In contrast to MDCK cells, passaging of V-isolates in
human kidney cell did not change their biological properties.
One important question remains. Could the glycosylation
pattern have any impact in the development of live attenu-
ated influenza vaccine? It is known that glycosylation of HA
is implicated in the antigenicity and immunogenicity of
viral glycoproteins as well as in the emergence of viral
variants with enhanced cytopathogenicity (Aytay and
Schulze, 1991; Inkster et al., 1993; Skehel et al., 1984). An
additional glycosylation site was identified earlier as a fac-
tor for increased pathogenicity in some studies (Deshpande
et al., 1987; Oxford et al., 1990; Perdue et al., 1995).
Recently it was reported that the HA glycosylation pattern is
implicated in the infectivity of influenza virus for macro-
phages (Reading et al., 2000). Moreover, the mannose re-
ceptor present on the surface of dendritic cells can facilitate
the capture of mannosylated antigens 100–1000 fold more
efficiently than of non-mannosylated for processing and
presentation to T cells (Engering et al., 1997). Therefore,
the array of Vero biosynthetic enzymes, providing a higher
number of terminal mannose residues at the surface of the
HA molecule, could have an impact in the infectivity and
immunogenicity of V-isolated viruses. The role of NA gly-
cosylation was not studied in this work and remains to be
investigated.
More studies have to be done to check whether this
“humanized” glycosylation pattern provided by Vero cells
could have an effect on the infectivity and therefore immu-
nogenicity of Vero derived vaccines. Our preliminary stud-
ies have shown that Vero derived H3N2 viruses were more
immunogenic for monkeys (Macaque mulata) compared to
analogous egg grown viruses. These studies are in progress.
Materials and methods
Cells
Vero (WHO-certified) and MDCK cell lines were ob-
tained from the American Type Culture Collection (ATCC).
Vero cells were adapted and further cultivated in DMEM/
Ham’s F12 (Biochrom) protein free medium (Kistner et al.,
1999). MDCK cells were cultivated in DMEM/Ham’s F12
(1:1) medium supplemented with 2% of heat inactivated
FCS (Gibco). The human kidney epithelial cell line HK42/1
was developed in the Institute of Applied Microbiology by
transfection of normal human kidney epithelial cells with a
plasmid encoding the early region of SV40 (Banerji et al.,
1983). The HK42/1 cell line was propagated in DMEM/
Ham’s F12 serum free medium. Composition of the media
is available upon request.
Primary isolation of influenza strains
Clinical specimens from influenza patients were obtained
from Public Health Laboratory Centre, Hong Kong (HK).
Vero, MDCK cells or CE were infected with combined throat
and nose swabs. Viruses of second passage were used for
sequencing. Viruses of swab specimens were sequenced di-
rectly from clinical material without any additional passages.
Propagation and titration of viruses
Viruses were propagated in Vero or MDCK cells in
DMEM/Ham’s F12 medium containing 5 g/ml of trypsin
(Sigma, T4549) at 33°C. Hemagglutination assay was per-
formed with 0.5% suspension of CRBC or HRBC (Group 0,
Rh) at 4°C. The infectious titer of viruses was determined in
Vero cells by plaque assay in the medium containing DMEM/
Ham’s F12, 4 mM L-glutamine; 5 g/ml of trypsin; 0,01% of
DEAE-dextran (Pharmacia), 0,6% of agar (Sigma) and ex-
pressed in plaque forming units (p.f.u.). Evaluation of virus
growth in CE was done by the infection of 10-days old em-
bryonated eggs with inoculum containing 104–105 p.f.u./egg of
a virus. Virus yield was assessed after 48 h by titration of
hemagglutination in allantoic fluid of each egg. Results are
presented as () in case of positive hemagglutination titer.
Subtyping of isolates
Determination of the isolates subtype was performed by
standard hemagglutination inhibition (HI) assay with diag-
nostic sheep antisera provided by the National Institute for
Biological Standards and Control (NIBSC, UK).
Virus purification
Virus containing fluid was clarified by centrifugation at
3500 g for 15 min at 4°C. Virus particles were isolated by
centrifugation in an SW28 rotor through a 30% sucrose
cushion in NTE buffer (0.1 M NaCl; 0.01 M Tris HCl; 0.001
M EDTA, pH 7.4) at 113000 g for 150 min at 4°C. The
pellet was resuspended in NTE buffer and applied to a
discontinuous gradient of 60 and 20% (w/v) sucrose in
NTE. Sucrose gradient was centrifuged in an SW41 rotor at
210000 g for 16 h at 4°C. The virus band was isolated,
diluted in NTE buffer, pelleted by centrifugation in a SW41
rotor at 210000 g for 30 min at 4°C and resuspended in
phosphate buffered saline (PBS).
Treatment of the viruses with endo- and exoglycosidases
Treatment with enzymes was performed at denaturing
and non denaturing conditions. Purified viruses were dena-
tured at 95°C for 10 min in PBS containing 0.5% (w/v)
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sodium dodecyl sulfate (SDS) and 1% (w/v) -mercapto-
ethanol. Excess SDS was blocked with Nonidet-P40 (final
concentration 1%). HA was digested with endoglycosidase
H (Endo H) in 0.05 M sodium citrate buffer, pH 5.5 (Endo
Hf, New England Biolabs, final concentration 180 mU/ml)
or endoglycosidase F (Endo F) in 0.05 M sodium phosphate
buffer pH 7.5 (PNGase F, New England Biolabs, final
concentration 90 mU/ml) for 18 h at 37°C. Treatment of
native viruses was done in PBS for 18 h at 37°C.
Treatment of native viruses with two -exomannosidases
(from Jack beans, Sigma, final concentration 5.4 U/ml and
Almonds, Sigma, final concentration 0.9 U/ml) or with a
mixture of -galactosidase (from Escherichia coli, Sigma,
final concentration 1.2 U/ml) and -N-acetylglucosamini-
dase (from Jack beans, Sigma final concentration 17.1
U/ml) was done at 33°C for 24 h. Prior to adding of -
galactosidase and -N-acetylglucosaminidase samples were
desialylated using Vibrio cholerae neuraminidase at 37°C
for 1 h (final concentration 74 mU/ml, Roche). As a nega-
tive control, PBS was added instead of enzymes and sam-
ples were treated the same way. Before the polyacrylamide
gel electrophoresis (PAGE), same volume of 2 sample
buffer (Invirtogen) was added and samples were incubated
at 95°C for 5 min. For samples digested with exoglycosi-
dases, hemagglutination assay was performed in the pres-
ence of 3 M NA inhibitor Neu5Ac-en.
Polyacrylamide gel electrophoresis and Western blot
analysis
SDS PAGE of virus preparations was carried out using
Tris-Glycine 16% gels (Invirtogen) as described (Laemmli,
1970). Western blotting was performed by electrophoretic
transfer of the proteins from the gel to a polyvinyl difluoride
membrane (Millipore) for 2 h at 200 mA. After overnight
blocking in TPBS (PBS with 0.1% Tween 20) containing
3% of skim milk, the membrane was incubated for 2 h with
specific sheep anti HA antisera (NIBSC), diluted 1:5000 in
TPBS buffer containing 1% of skim milk. Polyclonal sheep
antisera to HA of viruses A/Sydney/5/97 (H3N2) and
A/Beijing/262/93 (H1N1) were used. After intensive wash-
ing in TPBS the membrane was incubated for 1 h with
alkaline phosphatase conjugated to goat anti-sheep IgG di-
luted 1:10000 in TPBS containing 1% of skim milk. The
blot was developed in staining buffer (100 mM Tris HCl;
100 mM NaCl; 5 mM MgCl2, pH 9.5) with nitro blue
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.
Gene amplification
Viral RNA was extracted from tissue culture supernatant,
allantoic fluid, or swab material using Ultraspec reagent
(Biotecx). C-DNAs were synthesized using the M-MuLV
reverse transcriptase (MBI). Three overlapping parts of the
HA gene were amplified by PCR using specific primers
(sequence available upon request). The PCR products were
purified using Gel Band Purification Kit (Amersham Phar-
macia Biotech) and sequenced (SEQLAB GmbH, Germa-
ny). The sequences were analyzed using Lasergene 99 soft-
ware. The H3 numbering system was used throughout the
study for influenza A viruses. The GenBank accession num-
bers for the sequenced viruses are: AF386776, AF386781,
AF386764, AF386771, AY035588, AY035590, AY035591,
AY035592.
Acknowledgments
We thank Dr. I. Wilson for reviewing the manuscript.
This work was supported in part by Polymun Scientific
GmbH, Vienna, Austria.
References
Almond, J.W., 1977. A single gene determines the host range of influenza
virus. Nature 270, 617–618.
Aytay, S., Schulze, I.T., 1991. Single amino acid substitutions in the
hemagglutinin can alter the host range and receptor binding properties
of H1 strains of influenza A virus. J. Virol. 65, 3022–3028.
Azzi, A., Bartolomei-Corsi, O., Zakrzewska, K., Corcoran, T., Newman,
R., Robertson, J.S., Yates, P., Oxford, J.S., 1993. The haemagglutinins
of influenza A (H1N1) viruses in the ‘O’ or ‘D’ phases exhibit biolog-
ical and antigenic differences. Epidemiol. Infect. 111, 135–142.
Banerji, J., Olson, L., Schaffner, W., 1983. A lymphocyte-specific cellular
enhancer is located downstream of the joining region in immunoglob-
ulin heavy chain genes. Cell 33, 729–740.
Baum, L.G., Paulson, J.C., 1990. Sialyloligosaccharides of the respiratory
epithelium in the selection of human influenza virus receptor specific-
ity. Acta Histochem. Suppl. 40, 35–38.
Connor, R.J., Kawaoka, Y., Webster, R.G., Paulson, J.C., 1994. Receptor
specificity in human, avian, and equine H2 and H3 influenza virus
isolates. Virology 205, 17–23 doi: 10.1006/viro.1994.1615.
Couceiro, J.N., Paulson, J.C., Baum, L.G., 1993. Influenza virus strains
selectively recognize sialyloligosaccharides on human respiratory epi-
thelium; the role of the host cell in selection of hemagglutinin receptor
specificity. Virus Res. 29, 155–165.
Deshpande, K.L., Fried, V.A., Ando, M., Webster, R.G., 1987. Glycosyl-
ation affects cleavage of an H5N2 influenza virus hemagglutinin and
regulates virulence. Proc. Natl. Acad. Sci. USA 84, 36–40.
Engering, A.J., Cella, M., Fluitsma, D.M., Hoefsmit, E.C., Lanzavecchia,
A., Pieters, J., 1997. Mannose receptor mediated antigen uptake and
presentation in human dendritic cells. Adv. Exp. Med. Biol. 417,
183–187.
Fukuda, M., Kobata, A., 1993. Glycobiology. A Practical Approach, IRL
Press at Oxford University Press, Oxford.
Gambaryan, A.S., Marinina, V.P., Tuzikov, A.B., Bovin, N.V., Rudneva,
I.A., Sinitsyn, B.V., Shilov, A.A., Matrosovich, M.N., 1998. Effects of
host-dependent glycosylation of hemagglutinin on receptor-binding
properties on H1N1 human influenza A virus grown in MDCK cells
and in embryonated eggs. Virology 247, 170–177 doi: 10.1006/
viro.1998.9224.
Gambaryan, A.S., Robertson, J.S., Matrosovich, M.N., 1999. Effects of
egg-adaptation on the receptor-binding properties of human influenza
A and B viruses. Virology 258, 232–239 doi: 10.1006/viro.1999.9732.
Gambaryan, A.S., Tuzikov, A.B., Piskarev, V.E., Yamnikova, S.S., Lvov,
D.K., Robertson, J.S., Bovin, N.V., Matrosovich, M.N., 1997. Speci-
fication of receptor-binding phenotypes of influenza virus isolates from
different hosts using synthetic sialylglycopolymers: Non-egg-adapted
96 J. Romanova et al. / Virology 307 (2003) 90–97
human H1 and H3 influenza A and influenza B viruses share a common
high binding affinity for 6-sialyl(N-acetyllactosamine). Virology 232,
345–350 doi: 10.1006/viro.1997.8572.
Govorkova, E.A., Kaverin, N.V., Gubareva, L.V., Meignier, B., Webster,
R.G., 1995. Replication of influenza A viruses in a green monkey
kidney continuous cell line (Vero). J. Infect. Dis. 172, 250–253.
Govorkova, E.A., Matrosovich, M.N., Tuzikov, A.B., Bovin, N.V., Gerdil,
C., Fanget, B., Webster, R.G., 1999. Selection of receptor-binding
variants of human influenza A and B viruses in baby hamster kidney
cells. Virology 262, 31–38 doi: 10.1006/viro.1999.9892.
Grassauer, A., Egorov, A.Y., Ferko, B., Romanova, I., Katinger, H., Mus-
ter, T., 1998. A host restriction-based selection system for influenza
haemagglutinin transfectant viruses. J. Gen. Virol. 79, 1405–1409.
Inkster, M.D., Hinshaw, V.S., Schulze, I.T., 1993. The hemagglutinins of
duck and human H1 influenza viruses differ in sequence conservation
and in glycosylation. J. Virol. 67, 7436–7443.
Ito, T., Suzuki, Y., Takada, A., Kawamoto, A., Otsuki, K., Masuda, H.,
Yamada, M., Suzuki, T., Kida, H., Kawaoka, Y., 1997. Differences in
sialic acid-galactose linkages in the chicken egg amnion and allantois
influence human influenza virus receptor specificity and variant selec-
tion. J. Virol. 71, 3357–3362.
Katz, J.M., Naeve, C.W., Webster, R.G., 1987. Host cell-mediated varia-
tion in H3N2 influenza viruses. Virology 156, 386–395.
Katz, J.M., Wang, M., Webster, R.G., 1990. Direct sequencing of the HA
gene of influenza (H3N2) virus in original clinical samples reveals
sequence identity with mammalian cell-grown virus. J. Virol. 64,
1808–1811.
Katz, J.M., Webster, R.G., 1992. Amino acid sequence identity between
the HA1 of influenza A (H3N2) viruses grown in mammalian and
primary chick kidney cells. J. Gen. Virol. 73, 1159–1165.
Kemble, G.W., Henis, Y.I., White, J.M., 1993. GPI- and transmembrane-
anchored influenza hemagglutinin differ in structure and receptor bind-
ing activity. J. Cell Biol. 122, 1253–1265.
Kistner, O., Barrett, P.N., Mundt, W., Reiter, M., Schober-Bendixen, S.,
Eder, G., Dorner, F., 1999. Development of a Vero cell-derived influ-
enza whole virus vaccine. Dev. Biol. Stand. 98, 101–110 discussion
111.
Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly
of the head of bacteriophage T4. Nature 227, 680–685.
Matrosovich, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A.,
Castrucci, M.R., Donatelli, I., Kawaoka, Y., 2000. Early alterations of
the receptor-binding properties of H1, H2, and H3 avian influenza virus
hemagglutinins after their introduction into mammals. J. Virol. 74,
8502–8512.
Matrosovich, M.N., Gambaryan, A.S., Teneberg, S., Piskarev, V.E., Yam-
nikova, S.S., Lvov, D.K., Robertson, J.S., Karlsson, K.A., 1997. Avian
influenza A viruses differ from human viruses by recognition of sia-
lyloligosaccharides and gangliosides and by a higher conservation of
the HA receptor-binding site. Virology 233, 224–234 doi: 10.1006/
viro.1997.8580.
Medeiros, R., Escriou, N., Naffakh, N., Manuguerra, J.C., van der Werf, S.,
2001. Hemagglutinin residues of recent human A(H3N2) influenza
viruses that contribute to the inability to agglutinate chicken erythro-
cytes. Virology 289, 74–85 doi: 10.1006/viro.2001.1121.
Morishita, T., Nobusawa, E., Nakajima, K., Nakajima, S., 1996. Studies on
the molecular basis for loss of the ability of recent influenza A (H1N1)
virus strains to agglutinate chicken erythrocytes. J. Gen. Virol. 77,
2499–2506.
Muramatsu, T., Koide, N., Ceccarini, C., Atkinson, P.H., 1976. Character-
ization of mannose-labeled glycopeptides from human diploid cells and
their growth-dependent alterations. J. Biol. Chem. 251, 4673–4679.
Nobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y., Nakajima,
K., 1991. Comparison of complete amino acid sequences and receptor-
binding properties among 13 serotypes of hemagglutinins of influenza
A viruses. Virology 182, 475–485.
Nobusawa, E., Ishihara, H., Morishita, T., Sato, K., Nakajima, K., 2000.
Change in receptor-binding specificity of recent human influenza A
viruses (H3N2): a single amino acid change in hemagglutinin altered its
recognition of sialyloligosaccharides. Virology 278, 587–596 doi:
10.1006/viro.2000.0679.
Ohuchi, M., Ohuchi, R., Feldmann, A., Klenk, H.D., 1997. Regulation of
receptor binding affinity of influenza virus hemagglutinin by its carbo-
hydrate moiety. J. Virol. 71, 8377–8384.
Oxford, J.S., Schild, G.C., Corcoran, T., Newman, R., Major, D., Robert-
son, J., Bootman, J., Higgins, P., al-Nakib, W., Tyrrell, D.A., 1990. A
host-cell-selected variant of influenza B virus with a single nucleotide
substitution in HA affecting a potential glycosylation site was attenu-
ated in virulence for volunteers. Arch Virol. 110, 37–46.
Perdue, M.L., Latimer, J.W., Crawford, J.M., 1995. A novel carbohydrate
addition site on the hemagglutinin protein of a highly pathogenic H7
subtype avian influenza virus. Virology 213, 276–281.
Rajakumar, A., Swierkosz, E.M., Schulze, I.T., 1990. Sequence of an
influenza virus hemagglutinin determined directly from a clinical sam-
ple. Proc. Natl. Acad. Sci. USA 87, 4154–4158.
Reading, P.C., Miller, J.L., Anders, E.M., 2000. Involvement of the man-
nose receptor in infection of macrophages by influenza virus. J. Virol.
74, 5190–5197.
Robertson, J.S., 1999. An overview of host cell selection. Dev Biol Stand
98, 7–11 discussion 73-14.
Robertson, J.S., Bootman, J.S., Nicolson, C., Major, D., Robertson, E.W.,
Wood, J.M., 1990. The hemagglutinin of influenza B virus present in
clinical material is a single species identical to that of mammalian
cell-grown virus. Virology 179, 35–40.
Robertson, J.S., Naeve, C.W., Webster, R.G., Bootman, J.S., Newman, R.,
Schild, G.C., 1985. Alterations in the hemagglutinin associated with
adaptation of influenza B virus to growth in eggs. Virology 143,
166–174.
Robertson, J.S., Nicolson, C., Bootman, J.S., Major, D., Robertson, E.W.,
Wood, J.M., 1991. Sequence analysis of the haemagglutinin (HA) of
influenza A (H1N1) viruses present in clinical material and comparison
with the HA of laboratory-derived virus. J. Gen. Virol. 72, 2671–2677.
Rogers, G.N., D’Souza, B.L., 1989. Receptor binding properties of human
and animal H1 influenza virus isolates. Virology 173, 317–322.
Schepetiuk, S.K., Kok, T., 1993. The use of MDCK, MEK and LLC-MK2
cell lines with enzyme immunoassay for the isolation of influenza and
parainfluenza viruses from clinical specimens. J. Virol. Methods 42,
241–250.
Schild, G.C., Oxford, J.S., de Jong, J.C., Webster, R.G., 1983. Evidence for
host-cell selection of influenza virus antigenic variants. Nature 303,
706–709.
Skehel, J.J., Stevens, D.J., Daniels, R.S., Douglas, A.R., Knossow, M.,
Wilson, I.A., Wiley, D.C., 1984. A carbohydrate side chain on hem-
agglutinins of Hong Kong influenza viruses inhibits recognition by a
monoclonal antibody. Proc. Natl. Acad. Sci. USA 81, 1779–1783.
Suzuki, Y., 1994. Gangliosides as influenza virus receptors. Variation of
influenza viruses and their recognition of the receptor sialo-sugar
chains. Prog. Lipid Res. 33, 429–457.
Tong, N., Nobusawa, E., Morishita, M., Nakajima, S., Nakajima, K., 1998.
M protein correlates with the receptor-binding specificity of haemag-
glutinin protein of reassortant influenza A (H1N1) virus. J. Gen. Virol.
79, 2425–2434.
Vines, A., Wells, K., Matrosovich, M., Castrucci, M.R., Ito, T., Kawaoka,
Y., 1998. The role of influenza A virus hemagglutinin residues 226 and
228 in receptor specificity and host range restriction. J. Virol. 72,
7626–7631.
Wagner, R., Wolff, T., Herwig, A., Pleschka, S., Klenk, H.D., 2000.
Interdependence of hemagglutinin glycosylation and neuraminidase as
regulators of influenza virus growth: a study by reverse genetics.
J. Virol. 74, 6316–6323.
97J. Romanova et al. / Virology 307 (2003) 90–97
